factor (CRF) in stress-related responses were studied. 1. Microdialysis studies indicated that hypotension and footshock increased release of hypothalamic and cortical norepinephrine (NE). 2. A new voltammetric probe was designed to provide voltammetric data that a hypotensive agent, sodium nitroprusside, increases cortical NE secretion. 3. CRF infused into the locus coeruleus (LC) but not into surrounding structures, such as the parabrachial nucleus, increased secretion of cortical NE, supporting the notion that CRF affects the activity of LC-NE neurons. 4. Peripheral administration of interleukin-1 (IL-1) known to activate cerebral noradrenergic systems increased extracellular NE in the hypothalamus, and this activation was implicated in the induction of Fos protein in the hypothalamic paraventricular nucleus. 5. Chlordiazepoxide, administered systemically or locally decreased the secretion of NE induced by footshock and CRF. 6. Activation of noradrenergic systems by idazoxan or treatment with propranolol attenuated footshock-induced freezing and ultrasonic vocalization. Idazoxan did not alter the acquisition of conditioned fear, but it depressed the expression of that behavior. 7. 6-Hydroxydopamine lesions of the dorsal noradrenergic bundle did not consistently alter stress-induced behavioral patterns. Stressful stimuli are associated with activation of the hypothalamicpituitary-adrenal (HPA) axis which many have used to define a stress and concomitants activation of catecholaminergic system (the sympathetic nervous system, the adrenal medulla, and cerebral catecholaminergic systems). These systems are regarded to have complementary actions, but the relationships between them are poorly understood. In previous work, we and others have demonstrated that intracerebral injections of corticotropin-releasing factor (CRF) can mimic many of the endocrine, physiological, neurochemical and behavioral responses observed in stress (Dunn and Berridge, 1990) . However, the CNS noradrenergic system is also known to be activated in stress. Our previous studies have implicated noradrenergic activity in the stress-related changes in different behavioral paradigms. The pharmacological analyses of these stressrelated changes suggested that they were mediated primarily by noradrenergic neurons activating CRF-containing neurons. This sequential activation of noradrenergic and CRF systems rationalizes the coactivation of these two systems which may have complementary functions in the brain during stress and, possibly, influence each other reciprocally. The experiments were concerned with the cerebral mechanisms • involved in stress. The focus was on the HPA axis and locus coeruleus noradrenergic system (LC-NE) and its interaction with CRF. Effects of several different kinds of Stressors (physical, psychogenic, immune) were examined in laboratory rats.
II. EXPERIMENTS AND RESULTS

A.
Neurochemtcal responses
Sodium nitroprusside infusions activate cortical and hypothalamtc noradrenergic systems in rats.
To demonstrate the sensitivity, and therefore the suitability, of in vivo microdialysis for studies of cerebral norepinephrine (NE) release in stress, the responses to acute hypotension (a hemodynamic stressor)
induced by intravenous infusion of sodium nitroprusside (NP) was examined. NP treatment is known from electrophysiological data to activate the locus coeruleus noradrenergic neurons (LC-NE). In anaesthetized rats, iv infusion of NP caused a rapid decrease in blood pressure which lasted for the duration of the infusion but rapidly reversed when the infusion was terminated, it also enhanced the apparent release of NE in two LC projection fields, the medial prefrontal cortex (PFM) and medial hypothalamus. The increase in extracellular NE in the hypothalamus (67%) was greater than that in the PFM (41% The data were presented at the 1993 Annual Meeting of the Society for Neuroscience and published in Neuroscience Research Communications (Smagin, Swiergiel, and Dunn, 1994b) .
Cortical catecholamine secretion following intravenous
nltroprusside infusion: studies with in vivo yoltammetry.
Experiments like those described above but using in vivo voltammetry were performed. Using in vivo voltammetry, a real-time method of estimating changes in extracellular concentration of catecholamines, enables monitoring the time relationship between the NPinduced changes in blood pressure and the activity of the cortical noradrenergic system.
As in our previous experiments, iv administration of NP rapidly decreased blood pressure, but this rapidly reversed when the infusion was terminated. After a delay of between about 2 and 8 minutes (mean 5 min),
there was an increase in extracellular concentrations of a NE-like substance. Presumed cortical release of NE lasted for several minutes but had almost returned to baseline by the time the NP infusion was terminated at 15 minutes. In many cases, the first peak was followed by a second one, usually of smaller amplitude but more prolonged than the Local administration of idazoxan produced voltammograms showing peaks similar to the first peak, suggesting that the recorded oxidation current was related to release of NE (at least for the first peak). The voltammetric experiments confirm the results of the microdialysis studies and suggest that NP activates the noradrenergic system for a rather short period of time. However, the delayed voltammetric peaks may not be attributable to NE.
The present results suggest that reduction of blood pressure by nitroprusside infusion results' in a delayed noradrenergic response of cortical synaptic terminals; an initial rapid secretion of NE followed by a smaller and longer lasting release of NE or some other electroactive compound The system may function so that the cortex is cognizant of changes in peripheral physiology.
A manuscript has been submitted to Brain Research Bulletin ((Swiergiel, Palamarchouk, and Dunn, 1997a) , copy attached).
3.
In vivo voltammetric measurements of exogenous NE clearance in medial prefrontal cortex of DSP-4-treated rats.
DSP-4 is a potent and selective neurotoxin of central noradrenergic neurons. In rodents, a single systemic injection of DSP-4 produces longlasting reductions in NE concentrations and NE uptake capacity in brain.
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The reductions in NE and the loss of NE uptake sites are far more extensive in regions innervated by NE axons of the locus coeruleus than in regions supplied by non-coerulear noradrenergic cells. The aim of the experiments was to estimate in vivo contribution of synaptic uptake to the decrease in NE concentration in the prefrontal cortex of rats.
Adult Sprague-Dawley rats were injected with DSP-4 (50 mg/kg, ip).
72 hours later they were anesthetized with urethane and carbon fiber electrodes attached to micropipettes implanted into the prefrontal cortex.
Local applications of NE (500 jiM) were performed by pressure ejection of 10 to 200 nl of NE solution (doses of 0.5-10 pmol of NE). Rapid chronoamperometric measurements of the exogenous NE oxidation current were performed. The rate of clearance of NE from vicinity of the carbon electrode is reflected by an exponential decline in oxidation current.
Three major phenomena determine the rate of clearance of locally applied exogenous NE in brain: synaptic uptake, catabolism and diffusion.
The results showed that the rate of clearance of exogenously applied NE was substantially slower in DSP-4-treated animals than in the control ones. The mean rate constant describing the clearance of exogenous NE from the medial prefrontal cortex was 14.9 ± 1.5 sec-1 in intact and 8.5 ± 1.4 sec-1 in DSP-4 treated rats (p < 0.01) It is concluded that synaptic uptake of NE js largely dependent on intact axonal terminals. The decreased uptake delays return of the NE level to a baseline extracellular concentration.
The data were presented at the 1995 Annual Meeting of the Society for Neuroscience ( (Swiergiel, Palmartchouck, and Dunn, 1995) , copy attached). The method has been accepted for publication in the Journal of Neuroscience Methods ( (Swiergiel, Palamarchouk, and Dunn, 1997b 
5.
Corticotropirweleasing factor administered into the locus coeruleus but not the parabrachial nucleus stimulates norepinephrine release in the prefrontal cortex.
Several studies have indicated that intracerebroventricular application of CRF activated noradrenergic neurons in the brainstem LC (Valentino, Foote, and Aston-Jones, 1983 ) and NE metabolism in several brain regions ( (Dunn and Berridge, 1987; Lavicky and Dunn, 1993) . To assess whether CRF has direct effects on LC noradrenergic neurons, CRF was infused into the LC and concentrations of NE and its metabolites were The results were presented at the 1994 Annual Meeting of the Society for Neuroscience and
The First World Congress on Stress and have been published in Brain
Research Bulletin (Smagin, Swiergiel, and Dunn, 1994a ) (copies attached). Independent work in our laboratory has shown that interleukin-1 (IL-1) is a potent activator of cerebral NE systems (Dunn, 1988) . The noradrenergic activation is much more pronounced for the hypothalamus (innervated by brain stem nuclei A1 and A2), than other forebrain regions The results were published in Psychoneuroendocrinology (Smagin, Swiergiel, and Dunn, 1996) (copy attached).
7.
The role of cerebral noradrenergic system in the Fos response to interleukin-1.
Peripheral administration of IL-1 has been shown to activate induction of Fos protein in the brain, but the mechanism is not known. The data were presented at the 1995 Annual Meeting of the Society for Neuroscience (Dunn, Swiergiel, and Stone, 1995) and have now been published in Brain Research Bulletin (Dunn, Swiergiel, and Stone, 1996) (copies attached). initiation of footshock. In the hypothalamus, dialysate NE was augmented 50% above baseline, and in the PFM by 143%. CDP administration (5 mg/kg ip) had no statistically significant effects on the basal dialysate concentrations of NE, although there was a tendency towards a reduction.
CDP administered one sample before the footshock attenuated the increased dialysate concentrations of NE in footshock animals. These results suggested that footshock increased the synaptic release of NE in the cortex and hypothalamus, and that the response could be attenuated by CDP. The experimental design used could not distinguish whether CDP altered the input to LC noradrenergic neurons, or whether the benzodiazepines exerted a direct effect on the noradrenergic neurons.
Interestingly, when CDP was included in the solution used to perfuse the microdialysis probe, 1-5 mM decreased the footshock-induced increase in NE concentrations, suggesting the possibility of a local action of CDP at the noradrenergic terminals.
The results were presented at the 1994 Society for Neuroscience
Meeting ) (copy attached).
Chlordiazepoxfde attenuates overflow of extracellular NE in prefrontal cortex caused by CRF infused into LC.
In an earlier experiment, it was found that in anaesthetized rats administration of CRF into LC increased the concentration of NE in microdialysates collected from the prefrontal cortex. Those results were replicated in the experiment in which the effect of a benzodiazepine on the noradrenergic response was tested. Preliminary results indicated that the response could be attenuated by pretreatment with peripherally administered chlordiazepoxide (CDP, 5 mg/kg ip). (Figure 2 attached) . 
B. BEHAVIORAL RESPONSES IN STRESS
Several behavioral studies using different animal models of anxiety were used.
Effects of lesions of the dorsal noradrenergic ascending bundle (DNAB) on shock-induced freezing and vocalization in rats.
NE is known to play a role in fear and anxiety. The main evidence came from the effects of yohimbine that acts mainly at (X2-adrenoreceptors. Yohimbine causes anxiety in humans (Charney et a!., 1983) . Furthermore, several lines of physiological and pharmacological evidence led to the proposal that the locus coeruleus, the main noradrenergic nucleus in the brain stem, is a mediator of anxiety and its behavioral manifestations (Redmond, 1979) . Adult rats received bilateral infusions of 6-OHDA into the dorsal noradrenergic ascending bundle an extent that would suggest any significant role of the ascending NE system in this response. The study is to be repeated.
Results were presented at the 1993 Annual Meeting of the Society for Neuroscience ) (copy attached).
Effects of idazoxan and chlordiazepoxide on stress-induced freezing and ultrasonic vocalization.
The effects of idazoxan (1.25, 2.5 and 5 mg/kg) and CDP (2.5 and 5 mg/kg) on stress-induced freezing and ultrasonic vocalization were studied. Idazoxan is a potent and relatively specific <x 2 -adrenergic antagonist. It increases the activity of the noradrenergic system by accelerating the discharge rate of the LC-NE neurons and augmenting synaptic release of NE. There is widely accepted neuroanatomical, neurochemical, neurophysiological and behavioral evidence suggesting that the development of anxiety or fear is related, in part, to increased brain NE activity. In several experiments the hypothesis that increased noradrenergic activity contributes to the display of fear in several animal models of anxiety was tested. Preliminary results indicated that activation of NE system by idazoxan resulted in almost complete inhibition of stress-induced vocalization, and relatively small changes in stress-induced freezing. Although unexpected, the results agreed with previous experiments in which it had been demonstrated that depletion of the dorsal noradrenergic system with a neurotoxin DSP-4 dramatically enhanced stress-induced vocalization (Swiergiel, unpublished) . The experiments are to be completed. Several experiments were performed to determine whether pretreatment with idazoxan affects acquisition of a freezing response i.e.
display of conditioned freezing on the next day. On the first day, the rats were given idazoxan (1.25 or 2.5 mg/kg) and tested for footshock-induced freezing and vocalization. On the next day, display of conditioned freezing and vocalization was observed.
The results showed that an injection of idazoxan ten minutes before footshock did not change the latency to freeze or the total freezing time upon subsequent re-exposure to the same stressful environment. Thus, idazoxan does not affect (impair) acquisition of footshock-induced conditioned behavior. The experiments are to be completed.
Effect of idazoxan on expression of footshock-induced conditioned freezing.
As a sequel to the above study, it was decided to determine whether pretreatment with idazoxan affect the display of conditioned freezing. On the first day, rats were subjected to behavioral tests for footshockinduced freezing and vocalization. On the next day, the rats were given idazoxan (1.25 and 2.5 mg/kg) and the display of conditioned freezing and vocalization was observed.
The results showed that peripheral administration of idazoxan ten minutes before re-exposure to the stressful environment caused a significant decrease in total freezing time. Thus, idazoxan depressed previously conditioned footshock-induced freezing. In both experiments idazoxan did not alter nociception as determined in a hot-plate test. 15. Effects of propranolol on fear responses in rats.
Propranolol has been reported to have anxiolytic properties in several animal models of anxiety (Gorman and Dunn, 1993) . 
III. CONCLUSIONS
The experimental results obtained suggest that activation of brain noradrenergic systems can be quantified using in vivo microdialysis and in 
